$3.23
-0.015-0.46%
Last update: Nov 11, 4:00 PM
X4 Pharmaceuticals Inc (XFOR) Stock Price, Quote, News & History
XFORNASDAQ
FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare immunodeficiency disorder. Potential...
You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.
Other companies in X4 Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
X4 Pharmaceuticals has a consensus price target of $12.71.
The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $3.23 last updated November 11, 2026 at 4:00 PM EST.
There are no upcoming dividends for X4 Pharmaceuticals.
X4 Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for X4 Pharmaceuticals.
X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine...
